TNFSF14 and Hepatitis: In agreement with previous results from the concanavalin A-induced hepatitis model [30], the morbidly obese subjects [31] and the diabetic patients [32], circulating TNFSF14 concentrations were significantly increased in fibrotic nephropathy patients.